Crossmark

Emerging risks of lipid-lowering therapy and low LDL levels: implications for eye, brain, and new-onset diabetes

Crossref DOI link: https://doi.org/10.1186/s12944-025-02606-6

Published Online: 2025-05-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cure, Erkan https://orcid.org/0000-0001-7807-135X
Cumhur Cure, Medine https://orcid.org/0000-0001-9253-6459
License Information

Text and Data Mining valid from 2025-05-21

Version of Record valid from 2025-05-21
More Information

Article History

Received: 20 March 2025

Accepted: 10 May 2025

First Online: 21 May 2025

Declarations

:

: N/A.

: Not applicable.

: The authors declare no competing interests.